Abstract
Diagnostic exome sequencing (DES) is a powerful tool to analyze the pathogenic variants leading to development delay (DD) and intellectual disability (ID). Recently, heterozygous de novo mutation of the histone acetyltransferase encoding gene KAT6B has been recognized as causing a syndrome with congenital anomalies and intellectual disability, namely Say-Barber-Biesecker-Young-Simpson (SBBYS) syndrome. Here we report a case of SBBYS syndrome in a third generation Korean family affected with a missense mutation in KAT6B, c.2292C>T p.(His767Tyr) identified by DES. This is the first confirmed familial inherited mutation of the KAT6B reported worldwide. Our case emphasizes again the importance of basic physical examination and taking a family history. Furthermore, advances in genetic diagnostic tools are becoming key to identifying the etiology of DD and ID. This allows a physiatrist to predict the disease's clinical evolution with relative certainty, and offer an appropriate rehabilitation plan for patients.
-
Keywords: Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome, Intellectual disability, KAT6B protein
INTRODUCTION
Developmental delay (DD) and intellectual disability (ID) are major neuropsychological disorders in children, affecting 1%–3% of the general population. Of DD/ID cases, 17.4%–47.1% can be explained by genetic factors [
1].
Recently, diagnostic exome sequencing (DES) has been introduced to analyze the underlying cause of unexplained DD/ID with the discovery of a novel disease gene. Heterozygous
de novo mutation of the histone acetyltransferase encoding gene
KAT6B has been recognized to cause a syndrome with congenital anomalies and intellectual disability, namely Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) [
2].
Here, we present a case of SBBYSS in three generations of a Korean family affected with a missense mutation in KAT6B, c.2292C>T p.(His767Tyr) identified by DES. This is the first inherited KAT6B missense mutation reported worldwide.
CASE REPORT
The 3-year-old girl visited the department of rehabilitation medicine for evaluation due to developmental delay. She was the first born child of unrelated nonconsanguineous parents. At birth, mother and father were 23 and 30 years old, respectively. She was born in the 40th week of gestation after an uncomplicated pregnancy. Her birth weight was 3,500 g (50th–75th percentile). At the age 2, bilateral blepharophimosis and strabismus were noticed during an ophthalmologic evaluation. She sat at 10 months and walked at 18 months. Speech development was also slightly delayed. She started to say few simple words at 2 years, and was able to make phrases with 2–3 words at 3 years. Her social and emotional development declined, and she was described as shy, having little interaction with other people. On physical examination at the age of 3, her height was 90 cm (25th–50th percentile), weight 12 kg (below 25th percentile) and her occipitalfrontal circumference was 46 cm (below 3rd percentile). She had an immobile face, blepharophimosis, ptosis, a broad and flat nasal bridge, and a low set of large protruding ears (
Fig. 1). Further investigations, routine laboratory tests (including thyroid function tests, brain magnetic resonance imaging, electroencephalogram and joint X-rays) did not reveal any abnormality. During the examination, we noticed that her father also had a similar dysmorphic face. He had a contracture deformity in his metacarpophalangeal joints that prevented him from making a tight fist (
Fig. 1). He had graduated from college and was working in a manufacturing job as a simple laborer. According to the Korean–Wechsler Adult Intelligence Scale-IV, his intellectual quotient was 66, indicating intellectual disability. The pedigree acquired from the patient revealed that the patient's uncle was also diagnosed as moderately mentally retarded. Also, her deceased grandmother who was severely mentally retarded (
Fig. 2). Given the family history, we arranged a chromosomal microarray for the patient that yielded a normal result. DES was performed on the subject, followed by Sanger sequencing of the family trio (proband and both parents), identified
KAT6B missense mutation in c.2292C>T p.(His767Tyr) in the patient and her father. To better understand the relationship between the
KAT6B variant and the familiar inheritance pattern, additional familial testing included the grandfather and uncle. The uncle was found to carry the same
KAT6B variant (
Fig. 3). Considering these results and family history, the patient's grandmother was deemed an obligatory heterozygote. The variant was predicted to be deleterious in silico analysis using Sorting Intolerant from Tolerant (SIFT) with a score of 0.01 (resulting as damaging), Polymorphism Phenotyping v2 (PolyPhen-2) with a score of 0.87 (resulting as possibly damaging), and MutationTaster resulting as disease causing (prob: 0.999999996930964).
They were diagnosed as SBBYSS. Although a few cases with KAT6B have been reported worldwide, this is the first confirmed family inherited mutation of the KAT6B variant to date.
DISCUSSION
SBBYSS is very rare syndrome associated with the
KAT6B mutation. Clinical findings include a distinctive facial appearance with severe blepharophimosis, an immobile mask-like face, a bulbous nasal tip, and a small mouth with a thin upper lip, usually accompanied by mental retardation, delayed motor milestones, and significantly impaired speech [
3].
The
KAT6B gene is located on chromosome 10q22.2 and encodes lysine acetyltransferase 6B, a part of the histone H3 acetyltransferase complex in adult neural stem cells. Little is known about the function of the histone acetyltransferase, but it appears to regulate genes that are important for early development, including development of the skeleton and nervous system [
4]. Recently, similar
KAT6B mutations were identified in subjects with genitopatellar syndrome (GPS). GPS shows more severe conditions than in SBBYSS with characteristic features including structural brain defects (agenesis of corpus callosum), large joint contractures, genital anomalies, hydronephrosis with multiple renal cysts, and absent patella [
5].
Until now, 45 SBBYSS, 15 GPS patients, and 5 additional patients with combined phenotypes between the two syndromes have been reported with
KAT6B mutation [
235678]. Of those 65
KAT6B mutations, 53 mutations were located in exon 18. This is the last
KAT6B exon responsible for encoding acidic (A, Asp/Glu-rich) and transcriptional activation (TA, Ser/Met-rich) domains of the KAT6B [
6]. Gannon et al. [
7] suggested that SBBYSS mutations occurred more distally in exon 18 preserving the whole acidic domain but lacking the transcriptional activation domain that led to loss-of-function mutation. While GPS mutations were located more proximally in the same exon, losing both domains led to gain-of-function mutation. However recent studies identified mutations more proximal in exon 15, 16, 17 with the typical features of SBBYSS [
78]. The mutation occurred in exon 11 in our patient. Premature termination codon located proximal to the last exon is known to cause nonsense-mediated RNA decay [
9] resulting in haploinsufficiency of
KAT6B with mild SBBYSS phenotype (
Table 1). Clayton-Smith et al. [
2] also reported a patient with
KAT6B variants seen in the proximal part of exon 3 with mild SBBYSS phenotype. Our report confirms the previous observations that position of the mutation in the gene correlates with the phenotypes of the patients.
All
KAT6B variants identified so far have had heterozygous truncating
de novo with no familiar recurrence [
235678]. This report demonstrates a family with an inherited
KAT6B missense mutation as opposed to the
de novo mutations seen in SBBYSS and GPS.
In this report, DES was crucial for a correct diagnosis. DES has proven to be a powerful tool with a 25% diagnostic yield for the identification of pathogenic variants leading to Mendelian disorders in DD and ID [
10]. DES can detect single-nucleotide substitutions, and insertions or deletions, of 8 to 10 nucleotides or smaller. It is suggested that DES, together with array-based comparative genomic hybridization array, is a first-tier diagnostic tool to evaluate unexplained DD and ID. Patients with DD and ID often undergo a lengthy, time-consuming process for a definitive diagnosis, commonly known as a ‘diagnostic odyssey.’ Establishing an exact diagnosis in patients with DD and ID is important because it brings comfort to the patient's family, enables prediction of the disease's clinical course with relative certainty, allows formulation of an appropriate rehabilitation plan, and maintains general health. It also assists in accurately determining the risk of recurrence in subsequent pregnancies. Physiatrists are likely to be the first to encounter these patients. Therefore, to ensure a correct diagnosis, a careful physical examination that gathers detailed information on family history, and an appropriate genetic analysis, should be considered for patients with unexplained DD or ID.
To the best of our knowledge, this is the first molecular genetic analysis of a SBBYSS patient from the Korean population, and the first three generation inherited KAT6B missense mutation seen worldwide. This report broadens the phenotypic spectrum. Furthermore, the possibility of gonadal mosaicism must be considered to explain the rare familial recurrence of this condition. We also showed that DES can be useful tool to identify causative pathogenic variants in patients with DD and ID.
ACKNOWLEDGMENTS
ACKNOWLEDGMENTS
We thank the family of the patient for their participation in the study. The genetic analysis in this study was funded by Korean Foundation for Rare Disease.
CONFLICT OF INTEREST:
CONFLICT OF INTEREST: No potential conflict of interest relevant to this article was reported.
REFERENCES
- 1. Moeschler JB, Shevell M. American Academy of Pediatrics Committee on Genetics. Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics 2006;117:2304-2316.
- 2. Clayton-Smith J, O'Sullivan J, Daly S, Bhaskar S, Day R, Anderson B, et al. Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome. Am J Hum Genet 2011;89:675-681.
- 3. Campeau PM, Lu JT, Dawson BC, Fokkema IF, Robertson SP, Gibbs RA, et al. The KAT6B-related disorders genitopatellar syndrome and Ohdo/SBBYS syndrome have distinct clinical features reflecting distinct molecular mechanisms. Hum Mutat 2012;33:1520-1525.
- 4. Kraft M, Cirstea IC, Voss AK, Thomas T, Goehring I, Sheikh BN, et al. Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice. J Clin Invest 2011;121:3479-3491.
- 5. Simpson MA, Deshpande C, Dafou D, Vissers LE, Woollard WJ, Holder SE, et al. De novo mutations of the gene encoding the histone acetyltransferase KAT6B cause Genitopatellar syndrome. Am J Hum Genet 2012;90:290-294.
- 6. Vlckova M, Simandlova M, Zimmermann P, Stranecky V, Hartmannova H, Hodanova K, et al. A patient showing features of both SBBYSS and GPS supports the concept of a KAT6B-related disease spectrum, with mutations in mid-exon 18 possibly leading to combined phenotypes. Eur J Med Genet 2015;58:550-555.
- 7. Gannon T, Perveen R, Schlecht H, Ramsden S, Anderson B, Kerr B, et al. Further delineation of the KAT6B molecular and phenotypic spectrum. Eur J Hum Genet 2015;23:1165-1170.
- 8. Yilmaz R, Beleza-Meireles A, Price S, Oliveira R, Kubisch C, Clayton-Smith J, et al. A recurrent synonymous KAT6B mutation causes Say-Barber-Biesecker/Young-Simpson syndrome by inducing aberrant splicing. Am J Med Genet A 2015;167A:3006-3010.
- 9. Nagy E, Maquat LE. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci 1998;23:198-199.
- 10. Yang Y, Muzny DM, Reid JG, Bainbridge MN, Willis A, Ward PA, et al. Clinical whole-exome sequencing for the diagnosis of Mendelian disorders. N Engl J Med 2013;369:1502-1511.
Fig. 1Facial features of the proband (A), father (B, C), grandmother (D), uncle (E, F), and contracture deformity in metacarpophalangeal joints of father (G).
Fig. 2Three generation pedigree of the patient's family. Filled symbols represent affected members, open symbols represent unaffected members. Circles and squares represent females and males, respectively.
Fig. 3Sanger sequencing result of the proband, the patient's father and uncle confirms a missense mutation in KAT6B, c.2292C>T p.(His767Tyr).
Table 1Clinical findings of the reported family and the context of their frequency in previously published KAT6B mutations
Citations
Citations to this article as recorded by
- Phenotypic Characterization of Seven Pediatric Patients Diagnosed With KAT6B‐Related Disorders: Case Series and Review of the Literature
Vittorio Maglione, Antonio Pizzuti, Gioia Mastromoro, Eleonora Cresta, Paola Favata, Maria Cristina Digilio, Rossella Capolino, Maria Lisa Dentici, Lorenzo Sinibaldi, Antonio Novelli, Marco Tartaglia, Gianluca Terrin, Viviana Cardilli
American Journal of Medical Genetics Part A.2025;[Epub] CrossRef - Variable expressivity of a transmitted pathogenic KAT6B variant
Ninna Bager Rasmussen, Pernille Axél Gregersen, Trine Østergaard Nielsen, Line Graven Lyngdorf, Christine Kroer Nielsen, Casper Kruse, Michael Bayat, Philippe M. Campeau, Anne Skakkebæk
European Journal of Medical Genetics.2025; 76: 105020. CrossRef - De novo KAT6B mutation causes Say–Barber–Biesecker–Young–Simpson variant of Ohdo syndrome in an Iranian boy: a case report
Behzad Davarnia, Mohammad Panahi, Bahareh Rahimi, Hassan Anari, Reza Farajollahi, Ehsan Abbaspour Rodbaneh, Farhad Jeddi
Journal of Medical Case Reports.2024;[Epub] CrossRef - Clinical heterogeneity of polish patients with KAT6B–related disorder
Klaniewska Magdalena, Bolanowska‐Tyszko Anna, Latos‐Bielenska Anna, Jezela‐Stanek Aleksandra, Szczaluba Krzysztof, Krajewska‐Walasek Malgorzata, Ciara Elzbieta, Pelc Magdalena, Jurkiewicz Dorota, Stawinski Piotr, Zubkiewicz‐Kucharska Agnieszka, Rydzanicz
Molecular Genetics & Genomic Medicine.2023;[Epub] CrossRef - Delineation of a Phenotype Caused by a KAT6B Missense Variant Not Resembling Say-Barber-Biesecker-Young-Simpson and Genitopatellar Syndromes
Naoto Nishimura, Yumi Enomoto, Tatsuro Kumaki, Hiroaki Murakami, Azusa Ikeda, Tomohide Goto, Kenji Kurosawa
Molecular Syndromology.2022; 13(3): 221. CrossRef - A neonate with Say–Barber–Biesecker–Young–Simpson syndrome with a novel pathogenic mutation in KAT6B gene: A case report
Ji Hye Shin, Han Hyuk Lim, Mi Hyeon Gang, Seon Young Kim, Shin-seung Yang, Mea-young Chang
Journal of Genetic Medicine.2021; 18(2): 147. CrossRef - Mutación de novo en KAT6B, síndrome Say-Barber-Biesecker-Young-Simpson y trastorno específico del lenguaje
D.M. Fernández-Mayoralas, B. Calleja-Pérez, S. Álvarez, A. Fernández-Jaén
Neurología.2020; 35(8): 601. CrossRef - A novel pathogenic frameshift variant of KAT6B identified by clinical exome sequencing in a newborn with the Say–Barber–Biesecker–Young–Simpson syndrome
Rodrigo Mendez, Marisol Delea, Liliana Dain, Monica Rittler
Clinical Dysmorphology.2020; 29(1): 42. CrossRef - Further delineation of the clinical spectrum of KAT6B disorders and allelic series of pathogenic variants
Li Xin Zhang, Gabrielle Lemire, Claudia Gonzaga-Jauregui, Sirinart Molidperee, Carolina Galaz-Montoya, David S. Liu, Alain Verloes, Amelle G. Shillington, Kosuke Izumi, Alyssa L. Ritter, Beth Keena, Elaine Zackai, Dong Li, Elizabeth Bhoj, Jennifer M. Tarp
Genetics in Medicine.2020; 22(8): 1338. CrossRef - De novo KAT6B mutation, Say-Barber-Biesecker-Young-Simpson syndrome, and specific language impairment
D.M. Fernández-Mayoralas, B. Calleja-Pérez, S. Álvarez, A. Fernández-Jaén
Neurología (English Edition).2020; 35(8): 601. CrossRef - The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology
Naama Wiesel-Motiuk, Yehuda G. Assaraf
Drug Resistance Updates.2020; 53: 100729. CrossRef - Novel KAT6B proximal familial variant expands genotypic and phenotypic spectrum
T. Michael Yates, Claire L.M. Langley, Detelina Grozeva, F. Lucy Raymond, Diana S. Johnson
Clinical Genetics.2019; 95(2): 334. CrossRef - The many lives of KATs — detectors, integrators and modulators of the cellular environment
Bilal N. Sheikh, Asifa Akhtar
Nature Reviews Genetics.2019; 20(1): 7. CrossRef
, Jong Bum Park, MD1
